Page last updated: 2024-08-24

lurtotecan and Colonic Neoplasms

lurtotecan has been researched along with Colonic Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Besterman, JM; Brown, HR; Emerson, DL; Evans, MG; Leitner, PP; Luzzio, MJ; Shaffer, JE; Sternbach, DD; Uehling, D; Vuong, A1
Amantea, M; Colbern, GT; Dykes, DJ; Engbers, C; Hiller, A; Luzzio, M; Musterer, R; Pegg, E; Saville, R; Uster, P; Weng, S; Working, PK1

Other Studies

2 other study(ies) available for lurtotecan and Colonic Neoplasms

ArticleYear
In vivo antitumor activity of two new seven-substituted water-soluble camptothecin analogues.
    Cancer research, 1995, Feb-01, Volume: 55, Issue:3

    Topics: Animals; Antineoplastic Agents; Body Weight; Camptothecin; Cattle; Cell Division; Cell Line; Cell Survival; Colonic Neoplasms; Drug Screening Assays, Antitumor; Female; Humans; Mice; Mice, Nude; Thymus Gland; Topoisomerase I Inhibitors; Topotecan; Transplantation, Heterologous; Tumor Cells, Cultured

1995
Encapsulation of the topoisomerase I inhibitor GL147211C in pegylated (STEALTH) liposomes: pharmacokinetics and antitumor activity in HT29 colon tumor xenografts.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1998, Volume: 4, Issue:12

    Topics: Animals; Antineoplastic Agents; Camptothecin; Colonic Neoplasms; Drug Carriers; Drug Screening Assays, Antitumor; Enzyme Inhibitors; HT29 Cells; Humans; Liposomes; Male; Mice; Mice, Nude; Neoplasm Transplantation; Rats; Rats, Sprague-Dawley; Topoisomerase I Inhibitors; Transplantation, Heterologous; Treatment Outcome

1998